Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Ichikawa

Showing results (211-220 of 601) with videos related to

Pageof 61
Sort By:
The Journal of Medical Investigation : JMI|September 29, 2017
Construction of a combinatorial pipeline using two somatic variant  calling  methods  for whole exome sequence data of gastric cancerTomohiro Kohmoto, Kiyoshi Masuda, Takuya Naruto, et al.
Japanese Journal of Clinical Oncology|October 18, 2006
The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomasYuji Ueda, Atsushi Shiozaki, Hirosumi Itoi, et al.
Immunotherapy|February 25, 2017
Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancerHiroyuki Tada, Tsunao Kishida, Hitoshi Fujiwara, et al.
Anticancer Research|February 9, 2013
Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinomaShingo Nakashima, Atsushi Shiozaki, Daisuke Ichikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Multiple hepatocellular carcinomas successfully treated by combined therapies]Toshiya Ochiai, Teruhisa Sonoyama, Shojiro Kikuchi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinomaTsutomu Kawaguchi, Shuhei Komatsu, Daisuke Ichikawa, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 6, 2015
Histological mixed-type as an independent risk factor for nodal metastasis in submucosal gastric cancerMahito Miyamae, Shuhei Komatsu, Daisuke Ichikawa, et al.
Haematologica|June 8, 2019
Targetable driver mutations in multicentric reticulohistiocytosisNorihiro Murakami, Tomohisa Sakai, Eisuke Arai, et al.
American Journal of Physiology. Renal Physiology|January 17, 2014
Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activationDaisuke Ichikawa, Atsuko Kamijo-Ikemori, Takeshi Sugaya, et al.
Anticancer Research|April 28, 2026
Postoperative Changes in Nutritional Status and their Impact on Post-recurrence Prognosis After Pancreatoduodenectomy in Patients With Biliary Tract Carcinoma: An Age-stratified AnalysisWataru Izumo, Ryo Saito, Hidetake Amemiya, et al.
Pageof 61

Showing results (211-220 of 601) with videos related to

Sort By:
Pageof 61
The Journal of Medical Investigation : JMI|September 29, 2017
Construction of a combinatorial pipeline using two somatic variant  calling  methods  for whole exome sequence data of gastric cancerTomohiro Kohmoto, Kiyoshi Masuda, Takuya Naruto, et al.
Japanese Journal of Clinical Oncology|October 18, 2006
The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomasYuji Ueda, Atsushi Shiozaki, Hirosumi Itoi, et al.
Immunotherapy|February 25, 2017
Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancerHiroyuki Tada, Tsunao Kishida, Hitoshi Fujiwara, et al.
Anticancer Research|February 9, 2013
Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinomaShingo Nakashima, Atsushi Shiozaki, Daisuke Ichikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Multiple hepatocellular carcinomas successfully treated by combined therapies]Toshiya Ochiai, Teruhisa Sonoyama, Shojiro Kikuchi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinomaTsutomu Kawaguchi, Shuhei Komatsu, Daisuke Ichikawa, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 6, 2015
Histological mixed-type as an independent risk factor for nodal metastasis in submucosal gastric cancerMahito Miyamae, Shuhei Komatsu, Daisuke Ichikawa, et al.
Haematologica|June 8, 2019
Targetable driver mutations in multicentric reticulohistiocytosisNorihiro Murakami, Tomohisa Sakai, Eisuke Arai, et al.
American Journal of Physiology. Renal Physiology|January 17, 2014
Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activationDaisuke Ichikawa, Atsuko Kamijo-Ikemori, Takeshi Sugaya, et al.
Anticancer Research|April 28, 2026
Postoperative Changes in Nutritional Status and their Impact on Post-recurrence Prognosis After Pancreatoduodenectomy in Patients With Biliary Tract Carcinoma: An Age-stratified AnalysisWataru Izumo, Ryo Saito, Hidetake Amemiya, et al.
Pageof 61